Obermatt
See Similar Stocks →

Kobayashi Pharmaceutical

TYO:4967 · JP3301100008
Personal ProductsLarge

360

26
Medium confidence — indicative
Profit price12
Cash yield52
Price/Sales21
EV / Gross Profit32
Price/Book34
Return on Capital23
Return on Equity22
EBIT Margin33
Gross Profitability27

Cash truth not applicable for financial companies.

Sales growth34
Profit Growth16
Long-Term EPS Growth94
Reinvestment1
Price momentum65
Debt load97
Debt serviceability57
Liquidity100
Analyst ratings19
Opinion Changes50
Price Target Upside10
Market mood1
Value Creation7/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Kobayashi Pharmaceutical clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 3/5 components.

Profile

CountryJapan
IndustryPersonal Products
SizeLarge
TypePublic Company
ExchangeTSE
Founded1919
Employees58
Websitekobayashi.co.jp
ISINJP3301100008
Last UpdateApr 2, 2026
Index & Theme
Pain ManagementLifestyleFast-Moving Consumer GoodsNutraceuticalManufacturingPharmaceuticalSales

Description

Analysis

Middle-of-the-road

Kobayashi Pharmaceutical Co., Ltd. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is uncertain. The company scores 7/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
11
2023202420252026

All-time high

42

Jan 2024

All-time low

11

Jun 2026

Average rank

22

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
21
23
22
19
Price/Earnings
1
26
34
23
Price/Book
34
36
38
22
Dividend Yield
52
49
44
18
Value (overall)
16
19
18
7

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Kobayashi Pharmaceutical with its peers
TCI
TWO:8436
60
CountryTaiwan
IndustryPersonal Products
SizeSmall
Full Stock Analysis →
Comvita
NZC:CVT
26
CountryNew Zealand
IndustryPersonal Products
SizeSmall
Full Stock Analysis →
Kolmar Korea
KSC:161890
53
CountrySouth Korea
IndustryPersonal Products
SizeMedium
Full Stock Analysis →
Rohto Pharmaceutical
TYO:4527
81
CountryJapan
IndustryPersonal Products
SizeLarge
Full Stock Analysis →
Hengan International
HKG:1044
72
CountryChina
IndustryPersonal Products
SizeLarge
Full Stock Analysis →
Kao
TYO:4452
60
CountryJapan
IndustryPersonal Products
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →